Exogenus Therapeutics
Entity

  • Exogenus Therapeutics

    Created in 2015


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    5,004

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    3060-197 Cantanhede, Portugal

    Cantanhede

    Portugal

  • Employees

    Scale: 2-10

    Estimated: 13

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Exosome-based therapeutics

    Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for the treatment of severe lung inflammation, a condition with limited treatment options and a common cause of death following SARS‐CoV‐2 infection.

    Contact us at team@exogenus-t.com

    Biotechnology, Regenerative Medicine, Stem cells, exosomes, cell biology, and therapies

Catalyst interactions
Catalyst Type Tweets Articles
Blue Bio Value
Blue Bio Value
Environment, Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto)
Blue Bio Value
Environment, Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) 		Other

31 Aug 2022


Social network dynamics
Similar entities
BETA
Last news
Show all articles